Halaven, Injektionslösung

7680594890015 CH-59489 Injektionslösung
Halaven, Injektionslösung
Halaven, Injektionslösung
Halaven, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/02/2023
Summary of Product Characteristics
Français
17/02/2023
Summary of Product Characteristics
Italien
17/02/2023

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.88 MG Substance WIIS
(N/A)
0.1 ML Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 221.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2011

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
59489
Drug name
Halaven, Injektionslösung
Galenic form
LSINJ
ATC Code
L01XX41
Authorization status
Z
Dispensing category
A
First authorization
13/05/2011
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Mammakarzinom, inoperables Liposarkom

Package details

Description (FR)
HALAVEN sol inj 1 mg/2ml flac 2 ml
Description (DE)
HALAVEN Inj Lös 1 mg/2ml Durchstf 2 ml
Market launch
13/05/2011
Narcotic (BTM)
No